109 related articles for article (PubMed ID: 18789393)
1. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure.
Miller C; McMullin B; Ghaffari A; Stenzler A; Pick N; Roscoe D; Ghahary A; Road J; Av-Gay Y
Nitric Oxide; 2009 Feb; 20(1):16-23. PubMed ID: 18789393
[TBL] [Abstract][Full Text] [Related]
2. Potential application of gaseous nitric oxide as a topical antimicrobial agent.
Ghaffari A; Miller CC; McMullin B; Ghahary A
Nitric Oxide; 2006 Feb; 14(1):21-9. PubMed ID: 16188471
[TBL] [Abstract][Full Text] [Related]
3. A direct nitric oxide gas delivery system for bacterial and mammalian cell cultures.
Ghaffari A; Neil DH; Ardakani A; Road J; Ghahary A; Miller CC
Nitric Oxide; 2005 May; 12(3):129-40. PubMed ID: 15797841
[TBL] [Abstract][Full Text] [Related]
4. The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit.
McMullin BB; Chittock DR; Roscoe DL; Garcha H; Wang L; Miller CC
Respir Care; 2005 Nov; 50(11):1451-6. PubMed ID: 16253152
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections.
Ghaffari A; Jalili R; Ghaffari M; Miller C; Ghahary A
Wound Repair Regen; 2007; 15(3):368-77. PubMed ID: 17537124
[TBL] [Abstract][Full Text] [Related]
6. Inhaled nitric oxide decreases the bacterial load in a rat model of Pseudomonas aeruginosa pneumonia.
Miller CC; Hergott CA; Rohan M; Arsenault-Mehta K; Döring G; Mehta S
J Cyst Fibros; 2013 Dec; 12(6):817-20. PubMed ID: 23481089
[TBL] [Abstract][Full Text] [Related]
7. Gaseous nitric oxide exhibits minimal effect on skin fibroblast extracellular matrix gene expression and immune cell viability.
Moeen Rezakhanlou A; Miller C; McMullin B; Ghaffari A; Garcia R; Ghahary A
Cell Biol Int; 2011 Apr; 35(4):407-15. PubMed ID: 21155711
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of virulent bacterial biofilms with an enzymatic nitric oxide-releasing dressing.
Sulemankhil I; Ganopolsky JG; Dieni CA; Dan AF; Jones ML; Prakash S
Antimicrob Agents Chemother; 2012 Dec; 56(12):6095-103. PubMed ID: 22948868
[TBL] [Abstract][Full Text] [Related]
9. Safety of continuous 12-hour delivery of antimicrobial doses of inhaled nitric oxide during ex vivo lung perfusion.
Michaelsen VS; Ribeiro RVP; Ali A; Wang A; Gazzalle A; Keshavjee S; Cypel M
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):841-849.e1. PubMed ID: 33478833
[TBL] [Abstract][Full Text] [Related]
10. Gaseous nitric oxide reduces influenza infectivity in vitro.
Regev-Shoshani G; Vimalanathan S; McMullin B; Road J; Av-Gay Y; Miller C
Nitric Oxide; 2013 May; 31():48-53. PubMed ID: 23562771
[TBL] [Abstract][Full Text] [Related]
11. Mode of nitric oxide delivery affects antibacterial action.
Hall JR; Rouillard KR; Suchyta DJ; Brown MD; Ahonen MJR; Schoenfisc MH
ACS Biomater Sci Eng; 2020 Jan; 6(1):433-441. PubMed ID: 32671191
[TBL] [Abstract][Full Text] [Related]
12. A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis.
Jones ML; Ganopolsky JG; Labbé A; Prakash S
Appl Microbiol Biotechnol; 2010 Jun; 87(2):509-16. PubMed ID: 20300748
[TBL] [Abstract][Full Text] [Related]
13. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H
Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802
[TBL] [Abstract][Full Text] [Related]
14. Effect of therapeutic concentrations of nitric oxide on bacterial growth in vitro.
Hoehn T; Huebner J; Paboura E; Krause M; Leititis JU
Crit Care Med; 1998 Nov; 26(11):1857-62. PubMed ID: 9824079
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic nonhealing leg ulceration with gaseous nitric oxide: a case study.
Miller CC; Miller MK; Ghaffari A; Kunimoto B
J Cutan Med Surg; 2004; 8(4):233-8. PubMed ID: 16092001
[TBL] [Abstract][Full Text] [Related]
16. Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study.
Deppisch C; Herrmann G; Graepler-Mainka U; Wirtz H; Heyder S; Engel C; Marschal M; Miller CC; Riethmüller J
Infection; 2016 Aug; 44(4):513-20. PubMed ID: 26861246
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhaled nitric oxide following lung transplantation.
Yerebakan C; Ugurlucan M; Bayraktar S; Bethea BT; Conte JV
J Card Surg; 2009; 24(3):269-74. PubMed ID: 19438780
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
19. Gaseous nitrogen oxide promotes human lung cancer cell line A549 migration, invasion, and metastasis via iNOS-mediated MMP-2 production.
Chen JH; Lin HH; Chiang TA; Hsu JD; Ho HH; Lee YC; Wang CJ
Toxicol Sci; 2008 Dec; 106(2):364-75. PubMed ID: 18796497
[TBL] [Abstract][Full Text] [Related]
20. Examination of antimicrobial activity of selected non-antibiotic products.
Kruszewska H; Zareba T; Tyski S
Acta Pol Pharm; 2010; 67(6):733-6. PubMed ID: 21229899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
